Matches in Nanopublications for { ?s ?p "[Fas (CD95/Apo-1) mutations were previously reported as the genetic defect responsible for human lymphoproliferative syndrome associated with autoimmune manifestations (also known as autoimmune lymphoproliferative syndrome or Canale-Smith syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP2189.RAXuVQ4N3Zsrx7jM5BOVPNSY3r_-rZD-F2vl2d-Nujor0130_assertion description "[Fas (CD95/Apo-1) mutations were previously reported as the genetic defect responsible for human lymphoproliferative syndrome associated with autoimmune manifestations (also known as autoimmune lymphoproliferative syndrome or Canale-Smith syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP2189.RAXuVQ4N3Zsrx7jM5BOVPNSY3r_-rZD-F2vl2d-Nujor0130_provenance.
- assertion description "[Fas (CD95/Apo-1) mutations were previously reported as the genetic defect responsible for human lymphoproliferative syndrome associated with autoimmune manifestations (also known as autoimmune lymphoproliferative syndrome or Canale-Smith syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Fas (CD95/Apo-1) mutations were previously reported as the genetic defect responsible for human lymphoproliferative syndrome associated with autoimmune manifestations (also known as autoimmune lymphoproliferative syndrome or Canale-Smith syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP2081.RArA9WgdlO5fAQ-bQ3MW8TBpOtKsgHorjeSpo2gS9nI6E130_assertion description "[Fas (CD95/Apo-1) mutations were previously reported as the genetic defect responsible for human lymphoproliferative syndrome associated with autoimmune manifestations (also known as autoimmune lymphoproliferative syndrome or Canale-Smith syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP2081.RArA9WgdlO5fAQ-bQ3MW8TBpOtKsgHorjeSpo2gS9nI6E130_provenance.
- NP414.RAau5dv_kjvlMJJmMDZg2lPYoZnr0yJHxM4OmISY0aR0s130_assertion description "[Fas (CD95/Apo-1) mutations were previously reported as the genetic defect responsible for human lymphoproliferative syndrome associated with autoimmune manifestations (also known as autoimmune lymphoproliferative syndrome or Canale-Smith syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414.RAau5dv_kjvlMJJmMDZg2lPYoZnr0yJHxM4OmISY0aR0s130_provenance.
- NP264993.RA7qb-s7mOPqzn7ETy_SRAAX0Uyw5Jw6jmAzOUmt0Jlpo130_assertion description "[Fas (CD95/Apo-1) mutations were previously reported as the genetic defect responsible for human lymphoproliferative syndrome associated with autoimmune manifestations (also known as autoimmune lymphoproliferative syndrome or Canale-Smith syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264993.RA7qb-s7mOPqzn7ETy_SRAAX0Uyw5Jw6jmAzOUmt0Jlpo130_provenance.